highperformr logo

Turnstone Biologics's Overview

Total employees79
HeadquartersNew York
Founded2015

Turnstone Biologics is a clinical-stage biotechnology company focused on developing innovative cancer immunotherapies. Their primary approach involves engineering and advancing tumor-infiltrating lymphocyte (TIL) therapies designed to identify, target, and eradicate solid tumors. The company aims to overcome the limitations of current cancer treatments by providing potent and durable responses for patients with various types of cancer.

Where is Turnstone Biologics's Headquarters?

Turnstone Biologics officeTurnstone Biologics officeTurnstone Biologics officeTurnstone Biologics office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the main hub for corporate leadership, strategic planning, business development, investor relations, and administrative functions.

Notable Features:

Situated in a modern office building in the Hudson Square neighborhood of Manhattan, providing a professional environment conducive to its corporate functions. Specific internal architectural details are not publicly emphasized.

Work Culture:

The New York headquarters likely fosters a dynamic, results-oriented work culture focused on strategic decision-making, investor relations, and corporate governance, complementing the R&D-focused culture at its other sites.

HQ Significance:

The New York City location provides Turnstone Biologics with direct access to global financial markets, a rich pool of business talent, and proximity to key stakeholders in the investment community.

Values Reflected in HQ: The choice of New York for its corporate headquarters reflects ambition, a focus on strategic growth, access to capital markets, and a commitment to establishing a strong presence in the biopharmaceutical industry.

Location:

Turnstone Biologics supports its clinical development programs globally, primarily by conducting clinical trials in multiple countries to evaluate its TIL therapies. While its physical research and corporate offices are concentrated in North America (USA and Canada), its operational reach for clinical studies, patient recruitment, and potential scientific collaborations extends to key international regions relevant for oncology drug development.

Street Address:

99 Hudson Street, 5th Floor

City:

New York

State/Province:

NY

Country:

USA

Turnstone Biologics's Global Presence

La Jolla, California, USA

Address: 10835 Road to the Cure, Suite 150, San Diego, CA 92121

Leverages the rich biotech ecosystem in the San Diego area, providing access to specialized scientific talent, research institutions, and collaborators crucial for advancing their therapeutic pipeline.

Ottawa, Ontario, Canada

Address: 500 Palladium Drive, Suite 2300, Ottawa, ON K2V 1C2, Canada

Accesses Canadian research talent and the local biotechnology innovation ecosystem. May stem from foundational technology or historical collaborations in the region.

Buying Intent Signals for Turnstone Biologics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Turnstone Biologics

As of April 2025, Turnstone Biologics' leadership includes:

Sammy Farah, M.B.A., Ph.D. - President and Chief Executive Officer
Stewart Abbot, Ph.D. - Chief Scientific Officer
Jason Symons, J.D. - Chief Financial Officer and General Counsel
Adam C. Zylman, M.S. - Chief Technical Officer
Karin Baqi, M.B.A. - Chief People and Culture Officer

Investors of Turnstone Biologics

Turnstone Biologics has been backed by several prominent investors over the years, including:

Versant Ventures
OrbiMed
F-Prime Capital Partners
Sectoral Asset Management
Longitude Capital
Pivotal bioVenture Partners
PFM Health Sciences
Point72 Asset Management
Boxer Capital (Tavistock Group)

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

In the past 12 months (May 2023 - May 2024), Turnstone Biologics strengthened its executive team with the appointment of a new Chief People and Culture Officer in late 2023. No major executive departures have been publicly announced during this period.

New Appointments:

Karin Baqi, Karin Baqi appointed as new Chief People and Culture Officer to lead human resources strategy and foster organizational culture.

Technology (Tech Stack) used by Turnstone Biologics

Discover the tools Turnstone Biologics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Turnstone Biologics Email Formats and Examples

Turnstone Biologics commonly uses the email format combining the first initial of an employee's name followed by their last name, at the company's domain. For example, an employee named Jane Doe would likely have an email address like jdoe@turnstonebio.com.

flast@turnstonebio.com

Format

sfarah@turnstonebio.com

Example

85%

Success rate

News and media

GlobeNewswireMarch 28, 2024

Turnstone Biologics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Turnstone Biologics announced its financial results for the fourth quarter and full year ended December 31, 2023. The company also provided a corporate update, highlighting progress in its lead TIL therapy programs and upcoming milestones....more

GlobeNewswireDecember 1, 2023

Turnstone Biologics Appoints Karin Baqi as Chief People and Culture Officer

Turnstone Biologics announced the appointment of Karin Baqi, M.B.A., as Chief People and Culture Officer. Ms. Baqi brings extensive experience in building and scaling human resources functions within the biopharmaceutical industry....more

GlobeNewswireOctober 24, 2023

Turnstone Biologics Announces First Patient Dosed in Phase 1 Clinical Trial of Lead Selected TIL Candidate, TIDAL-01

The company announced that the first patient had been dosed in its Phase 1 clinical trial, TIDAL-01, evaluating its lead selected tumor-infiltrating lymphocyte (TIL) therapy candidate in patients with melanoma, colorectal, and breast cancers....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Turnstone Biologics, are just a search away.